Reuters logo
2 years ago
BRIEF-Ose Pharma International to launch phase 3 trial in lung cancer by end of year
September 1, 2015 / 5:16 PM / 2 years ago

BRIEF-Ose Pharma International to launch phase 3 trial in lung cancer by end of year

Sept 1 (Reuters) - Ose Pharma International SA :

* Ose Pharma sets up scientific steering committee and takes a first step in the launch of its phase 3 trial in lung cancer

* Phase 3 trial of Tedopi to be launched by end of year

Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below